tiprankstipranks
Advertisement

MTRA - ETF AI Analysis

Compare

Top Page

MTRA

Invesco International Growth Focus ETF (MTRA)

Rating:57Neutral
Price Target:
MTRA, the Invesco International Growth Focus ETF, has a solid but not top-tier rating, reflecting a mix of strong growth leaders and some holdings with notable risks. High-quality names like ASML, Tencent, and ResMed support the fund’s rating through robust revenue and profit growth and strategic investments in advanced technologies, even though some trade at expensive valuations. At the same time, holdings such as Sartorius Stedim Biotech, BAE Systems, and Alibaba face issues like bearish or mixed technical trends, cash flow pressures, and rich valuations, and the fund’s focus on international growth stocks means investors are exposed to sector and regional swings as well as higher volatility from premium-priced companies.
Positive Factors
Strong Leading Holding
The largest position, ASML Holding, has shown strong performance this year, providing a solid anchor for the portfolio.
Broad International Diversification
The fund spreads its investments across many countries outside the U.S., which can help reduce the impact of problems in any single market.
Exposure to Multiple Sectors
Holdings across industrials, health care, financials, consumer sectors, and more help avoid relying on just one part of the economy.
Negative Factors
Mixed Recent Performance
The ETF’s returns have been weak over the year to date and over the last three months, despite a stronger recent one-month rebound.
Several Lagging Top Holdings
Some major positions such as Tencent, Alibaba, and several health care names have been weak this year, which can drag on overall results.
Moderately High Expense Ratio
The fund’s expense ratio is on the higher side for an ETF, meaning more of the return is eaten up by fees each year.

MTRA vs. SPDR S&P 500 ETF (SPY)

MTRA Summary

The Invesco International Growth Focus ETF (MTRA) is an actively managed fund that looks for fast-growing companies outside the U.S., rather than tracking a set index. It invests across many countries, including the UK, France, the Netherlands, and more, and holds well-known names like ASML and Alibaba. This ETF may appeal to investors who want long-term growth and broader global diversification instead of only owning U.S. stocks. However, because it focuses on growth companies in international markets, its price can be more volatile and can go up and down significantly with global market conditions.
How much will it cost me?The Invesco International Growth Focus ETF (MTRA) has an expense ratio of 0.54%, which means you’ll pay $5.40 per year for every $1,000 invested. This is higher than average because the fund is actively managed, requiring more research and analysis to select stocks. Active management often leads to higher costs compared to passively managed funds that track an index.
What would affect this ETF?The Invesco International Growth Focus ETF (MTRA) could benefit from global economic recovery and increased demand for innovative technologies, healthcare advancements, and industrial growth, as these sectors make up a significant portion of its holdings. However, potential risks include geopolitical tensions, regulatory changes in key regions, and currency fluctuations, which could negatively impact the performance of its international investments. Additionally, rising interest rates or economic slowdowns in major markets could challenge growth-focused companies in the ETF.

MTRA Top 10 Holdings

MTRA leans heavily on international growth leaders, with Dutch chip-equipment giant ASML and France’s Schneider Electric doing much of the heavy lifting as their shares keep climbing. Industrial names like Siemens and Ferguson are also rising, giving the fund a solid backbone in Europe’s manufacturing and infrastructure story. On the flip side, Chinese tech titans Tencent and Alibaba are losing steam, acting as a drag despite their long-term potential. Overall, the ETF is globally diversified but tilted toward European industrials and growth names outside the U.S.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
ASML Holding NV5.09%$7.27M€472.52B126.77%
76
Outperform
Siemens3.71%$5.30M€184.16B29.67%
74
Outperform
Ferguson PLC3.38%$4.84M£37.88B61.75%
Schneider Electric3.29%$4.70M€153.25B37.30%
62
Neutral
Tencent Holdings 3.01%$4.31MHK$4.69T5.75%
75
Outperform
Resmed2.94%$4.20M$32.23B3.34%
76
Outperform
Sartorius Stedim Biotech2.83%$4.04M€18.35B-2.98%
61
Neutral
BAE Systems2.82%$4.04M£62.87B27.22%
61
Neutral
Lonza Group Ltd2.81%$4.02MCHF34.82B-6.96%
71
Outperform
Alibaba2.68%$3.83M$314.46B14.67%
68
Neutral

MTRA Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
25.51
Positive
100DMA
25.86
Positive
200DMA
25.83
Positive
Market Momentum
MACD
0.37
Negative
RSI
64.96
Neutral
STOCH
98.11
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For MTRA, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 26.23, equal to the 50-day MA of 25.51, and equal to the 200-day MA of 25.83, indicating a bullish trend. The MACD of 0.37 indicates Negative momentum. The RSI at 64.96 is Neutral, neither overbought nor oversold. The STOCH value of 98.11 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for MTRA.

MTRA Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$151.20M0.54%
57
Neutral
$488.52M0.55%
71
Outperform
$304.27M0.30%
58
Neutral
$284.23M0.60%
61
Neutral
$277.01M0.65%
63
Neutral
$106.62M0.45%
66
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
MTRA
Invesco International Growth Focus ETF
27.21
2.11
8.41%
OSEA
Harbor International Compounders ETF
AVDS
Avantis International Small Cap Equity ETF
QLTI
GMO International Quality ETF
UMMA
Wahed Dow Jones Islamic World ETF
IDYN
iShares International Equity Factor Rotation Active ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement